Applied Immune Technologies
Records under this name other than patents Applied Immune Technologies holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Applied Immune Technologies
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,001,642 | Affinity entities comprising a TCR-like antibody binding domain with high affinity and fine specificity and uses of same Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 12,252,547 | Affinity entities comprising a TCR-like antibody binding domain with high affinity and fine specificity and uses of same Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,088,569 | Immunogens for treatment of neoplastic and infectious disease Term ended Term ended Sep 10, 2023 · From the USPTO record | Term ended | Term ended Sep 10, 2023 | From the USPTO record |
| US 8,969,012 | Immunogens for Treatment of Neoplastic and Infectious Disease Term ended Term ended Mar 3, 2023 · Medium confidence | Term ended | Term ended Mar 3, 2023 | Medium confidence |
| US 7,718,166 | Immunotherapy for prostate cancer using recombinant bacille Calmette-Guerin expressing prostate specific antigens Lapsed on the fee record Ended May 18, 2022 · From the USPTO record | Lapsed on the fee record | Ended May 18, 2022 | From the USPTO record |